Publications by authors named "Patricia Ramos Gomez"

Article Synopsis
  • The RFC1 gene has a harmful repeat expansion (AAGGG) linked to disorders like CANVAS and late-onset ataxia, with a notable carrier frequency in the general population.
  • Two sisters affected by CANVAS were found to have a harmful genetic variant alongside this repeat expansion, indicating a genetic compound heterozygosity.
  • RNA analysis in these patients showed that the harmful variant had reduced expression due to a process that eliminates faulty mRNA, emphasizing the need for RFC1 gene sequencing in CANVAS diagnoses.
View Article and Find Full Text PDF

Alazami syndrome is a rare disorder with an autosomal recessive inheritance caused by pathogenic biallelic variants in the gene. Clinically, it is mainly characterized by short stature, intellectual disability, and dysmorphic facial features. However, the phenotype is not yet well-defined because less than 50 cases have been described to date.

View Article and Find Full Text PDF

Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is an autosomal recessive vascular disorder caused by biallellic variants in HTRA1. Recently, it has been reported that several heterozygous mutations in HTRA1 are responsible for a milder late-onset cerebral small vessel disease (CSVD) with an autosomal dominant pattern of inheritance. The majority of them are missense that affects the Htr1A protease activity due to a dominant-negative effect caused by defective trimerization or monomer activation.

View Article and Find Full Text PDF

Allan-Herndon-Dudley is an X-linked recessive syndrome caused by pathogenic variants in the SLC16A2 gene. Clinical manifestations are a consequence of impaired thyroid metabolism and aberrant transport of thyroid hormones to the brain. Carrier females are generally asymptomatic and may show subtle symptoms of the disease.

View Article and Find Full Text PDF

Autism spectrum disorder (ASD) is a prevalent and extremely heterogeneous neurodevelopmental disorder (NDD) with a strong genetic component. In recent years, the clinical relevance of de novo mutations to the aetiology of ASD has been demonstrated. Current guidelines recommend chromosomal microarray (CMA) and a testing as first-tier tests, but there is increasing evidence that support the use of NGS for the diagnosis of NDDs.

View Article and Find Full Text PDF